Françoise Coucheney

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Systemic Lupus Erythematosus

Bacillus Subtilis

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Sadek, Bernard Taminiau, Georges Daube, Panagiotis Sapountzis, Frédérique Chaucheyras-Durand, Mathieu Castex, Françoise Coucheney, Djamel Drider
Impact of Dietary Regime and Seasonality on Hindgut's Mycobiota Diversity in Dairy Cows. Microorganisms 12 (1) (2023)
Ali Sadek, Bernard Taminiau, Georges Daube, Panagiotis Sapountzis, Frédérique Chaucheyras-Durand, Mathieu Castex, Françoise Coucheney, Djamel Drider
Impact of Dietary Regime and Seasonality on Hindgut's Mycobiota Diversity in Dairy Cows. Microorganisms 12 (1) (2023)
Ali Sadek, Bernard Taminiau, Georges Daube, Panagiotis Sapountzis, Frédérique Chaucheyras-Durand, Mathieu Castex, Françoise Coucheney, Djamel Drider
Impact of Dietary Regime and Seasonality on Hindgut's Mycobiota Diversity in Dairy Cows. Microorganisms 12 (1) (2023)
Jean-Sébastien Guez, Françoise Coucheney, Joany Guy, Max Béchet, Pierre Fontanille, Nour-Eddine Chihib, Joachim Niehren, François Coutte, Philippe Jacques
Bioinformatics Modelling and Metabolic Engineering of the Branched Chain Amino Acid Pathway for Specific Production of Mycosubtilin Isoforms in Bacillus subtilis . Metabolites 12 (2) (2022)
Désiré Madi-Moussa, Barbara Deracinois, Radja Teiar, Yanyan Li, Marius Mihasan, Christophe Flahaut, Sylvie Rebuffat, Françoise Coucheney, Djamel Drider
Structure of Lacticaseicin 30 and Its Engineered Variants Revealed an Interplay between the N-Terminal and C-Terminal Regions in the Activity against Gram-Negative Bacteria. Pharmaceutics 14 (9) (2022)
Adrián Pérez-Ramos, Désiré Madi-Moussa, Françoise Coucheney, Djamel Drider
Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins. Microorganisms 9 (10) (2021)
Désiré Madi-Moussa, Yanath Belguesmia, Audrey Charlet, Djamel Drider, Françoise Coucheney
Lacticaseicin 30 and Colistin as a Promising Antibiotic Formulation against Gram-Negative β-Lactamase-Producing Strains and Colistin-Resistant Strains. Antibiotics (Basel, Switzerland) 11 (1) (2021)